China Universal Asset Management Company’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Buy |
61,995
+30,460
| +97% | +$283K | 0.05% | 231 |
|
|
2025
Q1 | $231K | Sell |
31,535
-1,801
| -5% | -$13.2K | 0.02% | 300 |
|
|
2024
Q4 | $285K | Buy |
33,336
+3,347
| +11% | +$28.6K | 0.03% | 299 |
|
|
2024
Q3 | $261K | Buy |
29,989
+11,793
| +65% | +$103K | 0.03% | 278 |
|
|
2024
Q2 | $124K | Sell |
18,196
-3,003
| -14% | -$20.5K | 0.02% | 285 |
|
|
2024
Q1 | $193K | Buy |
21,199
+12,007
| +131% | +$109K | 0.02% | 295 |
|
|
2023
Q4 | $41K | Buy |
9,192
+7,152
| +351% | +$31.9K | 0.01% | 387 |
|
|
2023
Q3 | $6.41K | Buy |
2,040
+1,024
| +101% | +$3.22K | ﹤0.01% | 375 |
|
|
2023
Q2 | $5.24K | Sell |
1,016
-27
| -3% | -$139 | ﹤0.01% | 365 |
|
|
2023
Q1 | $5.5K | Buy |
1,043
+261
| +33% | +$1.38K | ﹤0.01% | 357 |
|
|
2022
Q4 | $2.2K | Buy |
782
+61
| +8% | +$171 | ﹤0.01% | 367 |
|
|
2022
Q3 | $3K | Buy |
+721
| New | +$3K | ﹤0.01% | 329 |
|